January 5, 2010 OncoMed Pharmaceuticals, Inc. and Fluidigm Corporation Announce Strategic Collaboration
August 6, 2009 Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody
July 6, 2009 OncoMed Pharmaceuticals Appoints Sunil Patel senior Vice President, Corporate Development
December 12, 2008 OncoMed Pharmaceuticals Expands Series B Financing with Addition of Delphi Ventures and Names Deepa Pakianathan, Ph.D., to Board of Directors
November 4, 2008 OncoMed Pharmaceuticals Completes Series B Financing; Lead Cancer Stem Cell Product Candidate Enters Clinical Trials
December 10, 2007 GlaxoSmithKline And OncoMed Pharmaceuticals Form Strategic Alliance To Develop Cancer Stem Cell Antibody Therapeutics
October 30, 2007 OncoMed Pharmaceuticals Appoints William D. Waddill, Senior Vice President and Chief Financial Officer
February 21, 2007 OncoMed Pharmaceuticals Appoints Steven E. Benner, M.D., Senior Vice President and Chief Medical Officer
January 17, 2007 The New England Journal of Medicine Publishes Study Identifying A Tumorigenic Cancer Cell Gene Signature That Appears Predictive Of Clinical Outcomes
October 17, 2006 OncoMed Pharmaceuticals, Inc. Granted Fundamental Patent For Identifying Therapeutics Targeting Cancer Stem Cells
January 10, 2006 OncoMed Pharmaceuticals, Inc. Granted Fundamental Patent For Isolation And Use Of Solid Tumor Stem Cells
December 1, 2005 OncoMed Pharmaceuticals Appoints Paul J. Hastings President And Chief Executive Officer
